Abstract
In the brain, metallothionein (MT)-III exhibits a free radical scavenging activity. Here we examined the expression of MT-III mRNA in the basal ganglia of 6-hydroxydopamine (6-OHDA)-lesioned hemi-parkinsonian rats and its regulation by levodopa. The level of MT-III mRNA was significantly decreased in the striatum of 6-OHDA-lesioned side. Levodopa treatment significantly increased the expression of striatal MT-III mRNA in the non-lesioned side, but showed no significant effect in the 6-OHDA-lesioned side. These results suggest that the regulation of MT-III mRNA may be related to the progressive degeneration in parkinsonism. Copyright (C) 2000 Elsevier Science Ireland Ltd.
Original language | English |
---|---|
Pages (from-to) | 65-68 |
Number of pages | 4 |
Journal | Neuroscience Letters |
Volume | 293 |
Issue number | 1 |
DOIs | |
Publication status | Published - Oct 20 2000 |
Keywords
- Growth inhibitory factor
- Hemi-parkinsonism
- Levodopa
- Metallothionein-III
- Oxidative stress
- Parkinson's disease
ASJC Scopus subject areas
- Neuroscience(all)